
Safe storage and responsible disposal help protect patients from accidental poisoning and drug misuse while keeping medications stable and effective.
Vedolizumab (Entyvio) is indicated for adult patients with moderately to severely active ulcerative colitis and adult patients with moderately to severely active Crohn disease.
Medication Pearl of the Day: Vedolizumab (Entyvio)
Indication: Vedolizumab (Entyvio) is an integrin receptor antagonist indicated for adult patients with moderately to severely active ulcerative colitis (UC) and adult patients with moderately to severely active Crohn disease (CD).
Insight:
Source:





